Allergan pays 600 million fine 4 off label.

Quote
Anonymous said:
Why would anyone in the industry "cave" to a manager, RBD, or anyone else within a company, That pressures them to promote off label when they could just as easily gather the documentation and blow the shitheads in? As harshly as that question comes across, I'd love to hear an answer from someone who felt "trapped" in that position. I clearly must be missing something, having never experienced that type of pressure, but I honestly can't imagine just "going with the flow" and "hoping" someone doesn't get wise to what's up. Everytime I hear this happen to a company my first thought is always... "Shoot, I wish someone would be foolish enough, just once, to assume I'd keep my mouth shut." My sympathies to anyone caught up in it!
Click to expand...
Can't believe it NEVER happened to you.I worked for Allergan 3 different big pharma and they all asked for alot of off label.Including Allergan eye care div.
 






Anonymous said:
Why would anyone in the industry "cave" to a manager, RBD, or anyone else within a company, That pressures them to promote off label when they could just as easily gather the documentation and blow the shitheads in? As harshly as that question comes across, I'd love to hear an answer from someone who felt "trapped" in that position. I clearly must be missing something, having never experienced that type of pressure, but I honestly can't imagine just "going with the flow" and "hoping" someone doesn't get wise to what's up. Everytime I hear this happen to a company my first thought is always... "Shoot, I wish someone would be foolish enough, just once, to assume I'd keep my mouth shut." My sympathies to anyone caught up in it!
Click to expand...


Well first off you need to look back 7 years and not to the present......Allergan knew they were going to get their ass handed to them as long as 3 years ago, hence they began SUPER COMPLIANCE heavy over the last 4 years

But go back 7 years they were paying the Botox neuro RBM's and Reps just like the cosmetic side.....and the leadership structure and business models were very similar for both cosmetic and neuro therapeutic

Allergan built their cosmetic business by teaching people how to make a full time business out of cosmetic botox treatment

Allergan Pharma side taught neuro and derms how to convert 30-50% of their practice into Botox for derm and neuro uses.....approved or un approved

Hence the ICD9 Book and trial and error on code slamming......if it worked in one office....lets go teach another office how to do it as well

and as Paul Harvey used to say.......Now you have the "rest of the story" "Good Day"
 






Anonymous said:
Well first off you need to look back 7 years and not to the present......Allergan knew they were going to get their ass handed to them as long as 3 years ago, hence they began SUPER COMPLIANCE heavy over the last 4 years

But go back 7 years they were paying the Botox neuro RBM's and Reps just like the cosmetic side.....and the leadership structure and business models were very similar for both cosmetic and neuro therapeutic

Allergan built their cosmetic business by teaching people how to make a full time business out of cosmetic botox treatment

Allergan Pharma side taught neuro and derms how to convert 30-50% of their practice into Botox for derm and neuro uses.....approved or un approved

Hence the ICD9 Book and trial and error on code slamming......if it worked in one office....lets go teach another office how to do it as well

and as Paul Harvey used to say.......Now you have the "rest of the story" "Good Day"
Click to expand...

DOJ can go back tens years for unethical behavior.600 million was like slap on hand.Do you know how much this company makes in year way over 600 million.
 






Interesting how that developed, and I appreciate the explanation. You make a good point... it's important to remembered that the accusations and fines are not related to "today's promotional" activities.

My initial training in the industry (13 years back) couldn't have been more adamantly againsts off label promo, and I've never heard as much of a whisper of it at any company since. Who knows... if it had been presented to me early on in my career as "no big deal", maybe I too would have followed suit.
 






You can still file suit for their behavior that happen 10 or 5 years back if you have the documentation.Save voicemails from mangers forwarding off label success stories to regional manger,tape conversations with higher ups,save e-mails.Activity can be past as (far as 10 years).Doesn't have to be current.Like when we use to give eye kits away,now we sale them.PLEASE.... DOJ can go back to the kit activity 10 years ago,when they launched Zymar and they were giving doctors everything except for their first born (crazy shit during the launch).
 






Your right the whole ZAP campaign is TOTALLY off label in Eye surgeons Journals monthly (for cataracts).And Zymar indicated for pink eye ONLY.Such hypocrites.Your right Marketing team for Zymar should get fired.Then they can keep all the damaging documention(voice mails,e-mails) and file whistleblower suit and become millionaire (now that would be ironic).ZAP has been around for 3 or 4 years.I was so surprised that they got fined on Botox,I thought for sure it would be for Zymar.Do we even sale it for pink eye.If you think your about to be fired for what the company asked you to do for years,keep everything(all documents ,speaker fees for off label then file whistleblower suit.This bullshit!I hope they get for Zymar too.ZAP SOOO OFF_LABEL
 












U.S. Seeks to Join Pfizer Whistleblower Lawsuit
By Jef Feeley - Sep 21, 2010 5:52 PM CT
Email Share
Business ExchangeTwitterDeliciousDiggFacebookLinkedInNewsvinePropellerYahoo! BuzzPrint The U.S. Justice Department is seeking to join a whistleblower lawsuit over Pfizer Inc.’s organ transplant drug Rapamune alleging the medicine was illegally marketed, according to court papers.

The government’s lawyers are asking a federal judge in Philadelphia to allow them to take over litigating claims that officials of Pfizer’s Wyeth unit pushed the drug for unapproved uses and specifically targeted black patients.

“This means the government had determined that some or all of the allegations in our complaint are merit worthy,” Reuben Guttman, a Washington-based lawyer representing two former Wyeth employees who filed suit over the practices, said in a telephone interview today.

Rapamune is approved to help prevent the rejection of kidney transplants. The U.S. Food and Drug Administration last year found the drug may increase the risk of death and organ rejection if given during a liver transplant.

Pfizer officials said today Rapamune’s warning label included “appropriate caveats” about how the drug could be used safely in connection with transplants.

“Pfizer has previously disclosed that the company is cooperating with the U.S. government regarding its review of Wyeth’s promotional practices involving Rapamune,” Raymond Kerins, a Pfizer spokesman, said in an e-mailed statement. New York-based Pfizer bought Wyeth last year for $68 billion.

Marketing Tactics

After investigating the whistleblowers’ claims about Wyeth’s Rapamune marketing tactics, Justice Department lawyers concluded they had “good cause to intervene” in the case, according to a court filing. U.S. District Judge John R. Padova in Philadelphia still must approve the government’s request to join the 2005 suit.

The complaint was filed by Marlene Sandler and Scott Paris, two former Wyeth sales reps, who claim the drugmaker “directed their entire Rapamune sales force” to promote the drug among physicians involved in heart, lung, liver and pancreas transplants. The drug hasn’t been approved for use in any of those transplants, according to the complaint.

The whistleblowers also claim Wyeth officials offered doctors and hospitals kickbacks, in the form of speaker fees and grants, in exchange for Rapamune prescriptions.

Wyeth sales executives also targeted hospitals that served black populations in an effort to get doctors to switch transplant patients to Rapamune, according to the complaint. The FDA required the drugmaker in 2004 to include a black-box warning on Rapamune about such patient conversions, the suit said. That is the FDA’s highest safety warning.

Pfizer officials said in February that federal prosecutors in Oklahoma are investigating whether Wyeth’s Rapamune marketing campaign violated any criminal laws. The drugmaker acknowledged the probe in a U.S. Securities and Exchange Commission filing.
 






DOJ is on it!!!I think I am going to dig up some of my old training material and other stuff and contact the lawyers that represented the botox reps.We all should there usually 3 to 5 whistleblowers in case.
 




































Well I can tell you that we VERY CLEARLY promote off label...we say "DR, WILL U USE Zymar INSTEAD OF Vigamox FOR EVERY CATARACT SURGERY? HOW ABOUT FOR LASIK?" Um...that is "Off Label". I have tons of emails documenting this from my manager, old poa materials talking about use in surgery, and my MANAGER himself will ask my accts why they arent using it for surgerical prophylaxis if they're using a competitive product. Hell- I've even heard upper mgmt who rode w/ me do it!!! So there! We create surgery instructions for the patients on HOW TO USE OUR PRODUCTS around surgery, but we arent promoting it Off Label"? PLEASE- PLEASE- PLEASE FINE THIS COMPANY FOR PUTTING US IN A BAD POSITION! AGAIN!!!!
Peace out,
Eye div. of Allergan.
 






Anonymous said:
Well I can tell you that we VERY CLEARLY promote off label...we say "DR, WILL U USE Zymar INSTEAD OF Vigamox FOR EVERY CATARACT SURGERY? HOW ABOUT FOR LASIK?" Um...that is "Off Label". I have tons of emails documenting this from my manager, old poa materials talking about use in surgery, and my MANAGER himself will ask my accts why they arent using it for surgerical prophylaxis if they're using a competitive product. Hell- I've even heard upper mgmt who rode w/ me do it!!! So there! We create surgery instructions for the patients on HOW TO USE OUR PRODUCTS around surgery, but we arent promoting it Off Label"? PLEASE- PLEASE- PLEASE FINE THIS COMPANY FOR PUTTING US IN A BAD POSITION! AGAIN!!!!
Peace out,
Eye div. of Allergan.
Click to expand...
Contact the Botex attorneys and file suit as soon as possible!!!!!You have nothing to lose expect the DOJ saying "no" to your case.The company won't even know,because the cases are sealed.
 












Anonymous said:
Yes your doctor can purchase thru Canadian RX's. It all comes from the same FDA approved plant in the UK. Due to price regulation in Canada his price is much lower but it is the same Botox just packaged different.
Click to expand...

That is illegal and the doctor could lose his medical license for it. That is importing drugs across the US border. It does not matter if it was made by Allergan. It is a US Customs violation.
 












This company is lead by morons... layoff people when there's no need to save money for the excutives bonus. They sue the mother of a dead child for principle reasons. Principles? you wouldn't know if it hit you in the face. Pyott, Ball, I hope the BODs fire your a**..
 






Top Bottom
Back
Quote